Envision Healthcare
EVHC
Delayed Nyse - 08/22 10:04:10 pm
51.41USD
+0.29%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 20162017
Sales3 6967 898
EBITDA6311 068
Operating profit (EBIT)568921
Pre-Tax Profit (EBT)--
Net income-27,743,0
EPS ( $ )-0,470,01
Dividend per Share ( $ )--
Yield--
Announcement Date02/28/2017
09:15pm
-
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 20162017
Debt5 5075 730
Finance--
Operating income (EBITDA)6311 068
Leverage
(Debt/EBITDA)
8,73x5,37x
Capital Expenditure99,5141
Book Value Per Share (BVPS)57,3 $54,7 $
Cash Flow per Share6,66 $6,63 $
Announcement Date02/28/2017
09:15pm
-
Balance Sheet Analysis
Financial Ratios
Size 2017e 2018e
Capitalization 6 194 M$ -
Entreprise Value (EV) 11 924 M$ 11 235 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 3 854x 17,3x
Capitalization / Revenue 0,78x 0,72x
EV / Revenue 1,51x 1,30x
EV / EBITDA 11,2x 9,34x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 0,94x 0,90x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 11,7% 12,2%
operating Leverage (Delta EBIT / Delta Sales) 0,55x 1,53x
Net Margin (Net Profit / Revenue) 0,54% 4,16%
ROA (Net Profit / Asset) 2,10% 2,60%
ROE (Net Profit / Equities) 6,01% 6,85%
Rate of Dividend - -
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   1,78% 0,95%
Cash Flow / Sales 10,1% 7,50%
Capital Intensity (Assets / Sales) 0,26x 1,60x
Financial Leverage (Net Debt / EBITDA) 5,37x 4,19x
Price Earning Ratio
BNA & Dividende